Brazil Market (US & EU Listed) Investment Strategy
With Brazil's stock market appearing undervalued relative to global peers, a unique opportunity may be present for investors. This basket provides exposure to this theme through US and EU-listed multinational companies with significant business operations in Brazil.
Your Basket's Financial Footprint
Aggregated market capitalisation data for the Brazil stock-market basket showing large-cap concentration and full holdings breakdown.
- Large-cap dominance suggests lower volatility and closer tracking of broad market moves, likely reducing idiosyncratic risk.
- Suitable as a core holding for diversification rather than a speculative, high-growth allocation.
- Expect steady long-term appreciation, not explosive short-term gains; growth likely gradual.
ERJ: $11.77B
VALE: $51.22B
PBR: $72.97B
- Other
About This Group of Stocks
Our Expert Thinking
Brazil's stock market appears undervalued relative to global peers, creating a unique opportunity for investors. Rather than navigating the complexities of direct access to Brazil's B3 exchange, this approach focuses on globally-listed multinational corporations with substantial economic ties to Brazil. These companies span key sectors from agribusiness and commodities to finance and consumer goods, offering diversified exposure to Brazil's economic potential.
What You Need to Know
This group provides simplified access to Brazil's economy through US and EU-listed companies, avoiding the need for specialised platforms. The selection includes firms deeply embedded in Brazil's growth story, from agricultural exporters to financial infrastructure providers. These companies typically have robust governance standards and offer a strategic way to participate in Brazil's potential upside whilst maintaining international market accessibility.
Why These Stocks
Each company was handpicked based on their significant revenue or operational footprint in Brazil. The selection captures firms that are either key players within Brazil or critical enablers of its growth, including global agribusiness leaders, financial service providers, and major industrial companies with substantial manufacturing and distribution networks. This curated approach ensures meaningful exposure to Brazil's economic trajectory through established, internationally-traded corporations.
Why You'll Want to Watch These Stocks
Undervalued Market Opportunity
Brazil's stock market appears undervalued compared to global peers, potentially offering attractive entry points. These globally-listed companies provide exposure to this opportunity without the complexity of direct Brazilian market access.
Economic Growth Catalysts
From agribusiness giants to financial infrastructure providers, these companies are deeply embedded in Brazil's economic engine. Their performance is closely tied to the nation's growth trajectory and expanding consumer markets.
Strategic Market Access
Professional analysts have handpicked these companies for their significant Brazilian operations and revenue exposure. It's a curated way to participate in one of Latin America's largest economies through established, internationally-traded corporations.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Digital Brazil Media | US & EU Listed Companies
Brazil's rapid digital adoption and urbanized population are fuelling significant growth in online media and entertainment consumption. This basket provides exposure to the US/EU-listed global giants in streaming, gaming, and music that serve this expanding Brazilian market.
Clinical Trial Tech: Growth vs Competition Risks
Thermo Fisher's multi-billion dollar acquisition of Clario, a clinical trial data company, signals a major industry shift towards digital solutions. This creates a compelling investment case for companies specializing in the software and data analytics that power modern drug development.
US China Tariff Cuts: Investment Plays for 2025
Former President Trump's plan to reduce tariffs on Chinese goods in exchange for cooperation on key issues signals a potential thaw in trade relations. This could create a significant tailwind for U.S. companies in the agriculture and technology sectors that have major exposure to China.